Showing results (1211-1220 of 1,823) with videos related to

Sort By:
Pageof 183
Transplantation and Cellular Therapy|January 22, 2026
Long-term survival gains after allogeneic hematopoietic stem cell transplant are driven by reductions in non-relapse mortality: A 35-Year Statewide Australian cohort studyAlia Cibich, Gauri Wechalekar, Naranie Shanmuganathan, et al.
Transplantation and Cellular Therapy|January 15, 2026
Towards Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task ForceAlina Markova, Stephanie J Lee, Badri Modi, et al.
Transplantation and Cellular Therapy|January 21, 2026
Tandem conditioning-based myeloablative HSCT for pediatric patients with refractory myeloid leukemiasJae Won Yoo, Suejung Jo, Seongkoo Kim, et al.
Transplantation and Cellular Therapy|January 17, 2026
Disparities in Allogeneic Hematopoietic Stem Cell Transplantation Among Acute Myeloid Leukemia PatientsLixin Cindy Kang, Mark A Fiala, Kimberly J Johnson
Transplantation and Cellular Therapy|February 15, 2026
Outcomes of DPB1 Mismatch in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Time to Move Past Chromosome 6?Hamid Farajifard, Atieh Karimzadeh, Maryam Behfar, et al.
Transplantation and Cellular Therapy|January 27, 2026
Subsequent neoplasms after umbilical cord blood transplantation in the Japanese and European populationsJunya Kanda, Fernanda Volt, Hanadi Rafii, et al.
Transplantation and Cellular Therapy|February 10, 2026
Desensitization therapy using sirolimus and anti-CD20 monoclonal antibody based regimen in haploidentical transplant recipients positive for donor-specific anti-HLA antibodiesNing Ma, Xiang-Yu Zhao, Lan-Ping Xu, et al.
Transplantation and Cellular Therapy|February 9, 2026
Breaking Access Barriers to Autologous Stem Cell Transplant and Chimeric Antigen Receptor T Cell therapy in Hematological Malignancies - an ASTCT-NMDP ACCESS InitiativePashna N Munshi, Carrie Yuen, Taha Al-Juhaishi, et al.
Transplantation and Cellular Therapy|December 7, 2025
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily C Merkel, Ted Gooley, Monica S Thakar, et al.
Transplantation and Cellular Therapy|November 28, 2025
Repeatable Battery for the Assessment of Neuropsychological Status: Preliminary Utility for Subacute Cognitive Monitoring after Immune Effector Cell-Associated Neurotoxicity Syndrome after Chimeric Antigen Receptor T-Cell TherapyChristina Kazzi, Sarah P Griffith, Katherine Y Ko, et al.
Pageof 183